Amy's strategic approach to intangible asset protection often results in tangible value to client businesses. By understanding the science behind innovations and their commercial potential, she creates tailored exclusivity profiles that align with commercial objectives. This unique perspective allows her to ask critical questions others might overlook. Having had the privilege to support Nobel, NCI, Burger, and Kettering award winners in medicinal chemistry research, Amy welcomes the opportunity to play a role in advancing innovation.